Market Insights report
Anxiety and related sleep disorders are some of the most common mental health disorders around the world. They can develop differently from person to person, ranging from generalized to social and phobic anxiety and from obsessive compulsive disorder (OCD) to post-traumatic disorder (PTSD). Anxiety is often a cause of sleeping problems, but sleep deprivation can also often be the reason behind an anxiety disorder.
The proportion of the worldwide population with diagnosed cases (prevalence) varies between countries, ranging from 2.5% to 7%, with women being more likely to report symptoms than men. There was, however, a rise in diagnosed cases right after the peak of COVID-19, which can be attributed to the rise in stress levels and uncertainty brought about by the unprecedented times. This increase in diagnoses resulted in a global spike in revenues for the Anxiety and Related Sleep Disorders market in the first year of the pandemic.
What's included?
This market report on Anxiety and Related Sleep Disorders provides detailed insights into the market from a global perspective. Besides all relevant market figures like worldwide revenues from 2016 to 2028, we have deep-dived into regional and country comparisons with a focus on Europe and the Americas.
Anxiety and Related Sleep Disorders market was valued at 8.51 billion USD in 2022 and is expected to grow steadily between 2022 and 2028. The advancements in the detection of anxiety as well as the increasing acceptance of medication are driving the market. The largest markets include developed countries including the US, China, Japan, and Canada.
The major players include Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.
Overview
Market numbers
We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)